Johnson & Johnson, Risperdal Maker Hit With $8B Verdict - NBC10 Boston
National & International News
The day’s top national and international news

Johnson & Johnson, Risperdal Maker Hit With $8B Verdict

Johnson & Johnson used an organized scheme to make billions of dollars while illegally marketing and promoting a drug, attorneys Tom Kline and Jason Itkin said in a statement

Find NBC Boston in your area

Channel 10 on most providers

Channel 15, 60 and 8 Over the Air

    processing...

    NEWSLETTERS

    Johnson & Johnson, Risperdal Maker Hit With $8B Verdict
    Mario Tama/Getty Images
    In this Aug. 26, 2019, file photo, a sign is posted at the Johnson & Johnson campus in Irvine, California.

    A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys.

    Johnson and Johnson immediately denounced the award after the jury's decision in the Court of Common pleas, saying it's "excessive and unfounded" and vowing immediate action to overturn it.

    The antipsychotic drug Risperdal is at the center of the lawsuit, with the plaintiff's attorneys arguing it's linked to abnormal growth of female breast tissue in boys, an incurable condition known as gynecomastia.

    Johnson & Johnson used an organized scheme to make billions of dollars while illegally marketing and promoting the drug, attorneys Tom Kline and Jason Itkin said in a statement.

    Trapped Hong Kong Protesters Rappel Down Hoses to Escape

    [NATL] Trapped Hong Kong Protesters Rappel Down Hoses to Escape

    Harrowing footage shows protesters trapped inside Hong Kong Polytechnic University rappelling down hoses to escape a police siege. About 100 anti-government protesters remain inside the university on a third day of clashes between protesters and police. 

    (Published Tuesday, Nov. 19, 2019)

    Kline and Itkin said that Johnson & Johnson was "a corporation that valued profits over safety and profits over patients." Thousands of lawsuits have been filed over the drug, but the attorneys said this was the first in which a jury decided whether to award punitive damages and came up with an amount.

    Johnson & Johnson said in a statement on its website it was confident that the award would be overturned, calling it "grossly disproportionate" with the initial compensatory damage award and "a clear violation of due process."

    Johnson & Johnson said the court's exclusion of key evidence left it unable to present a meaningful defense, including what they said was a drug label that "clearly and appropriately outlined the risks associated with the medicine" or Risperdal's benefits for patients with serious mental illness. They also said the plaintiff's attorneys failed to present any evidence of actual harm.

    "This decision is inconsistent with multiple determinations outside of Philadelphia regarding the adequacy of the Risperdal labeling, the medicine's efficacy, and findings in support of the company," Johnson & Johnson said. "We will be immediately moving to set aside this excessive and unfounded verdict."